Xylometazoline

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

IndicationThis section has been translated automatically.

Pregnancy/nursing periodThis section has been translated automatically.

Contraindicated.

Dosage and method of useThis section has been translated automatically.

Nasal spray/gel/drops: Use 1-3 times/day.

Remember! Limit the application time to max. 14 days!

Standard concentrationThis section has been translated automatically.

Nose drops/spray/gel: 0.025-0.1%.

Undesirable effectsThis section has been translated automatically.

In case of prolonged or frequent use, especially beyond the recommended application period, occasional burning of the nasal mucous membrane after application, dry nasal mucous membrane, rhinitis sicca or sneezing. Overdose rarely leads to tachycardia, increase in blood pressure and hyperhidrosis. Very rarely restlessness, insomnia, tiredness or headaches. Occasionally nausea or dizziness.

ContraindicationThis section has been translated automatically.

Narrow-angle glaucoma.

PreparationsThis section has been translated automatically.

Otriven, Olynth

Authors

Last updated on: 29.10.2020